Scilex Holding Co. (SCLX)
2.82
-0.03
(-1.05%)
USD |
NASDAQ |
Oct 15, 16:00
2.87
+0.05
(+1.77%)
After-Hours: 20:00
Scilex Net Income (Quarterly) : -116.22M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -116.22M |
| March 31, 2026 | -45.65M |
| December 31, 2025 | -46.10M |
| September 30, 2025 | -257.82M |
| June 30, 2025 | -87.80M |
| March 31, 2025 | -26.08M |
| December 31, 2024 | -6.46M |
| September 30, 2024 | -4.388M |
| June 30, 2024 | -37.58M |
| March 31, 2024 | -24.38M |
| December 31, 2023 | -21.40M |
| September 30, 2023 | -35.53M |
| Date | Value |
|---|---|
| June 30, 2023 | -26.65M |
| March 31, 2023 | -30.75M |
| December 31, 2022 | -23.99M |
| September 30, 2022 | 21.50M |
| June 30, 2022 | -17.84M |
| March 31, 2022 | -9.143M |
| December 31, 2021 | 1.133M |
| September 30, 2021 | -1.444M |
| June 30, 2021 | -0.2337M |
| March 31, 2021 | 1.329M |
| December 31, 2020 | -0.0004M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 7.642M |
| Total Expenses (Quarterly) | 122.37M |
| EPS Diluted (Quarterly) | -16.65 |
| Enterprise Value | 123.08M |
| Gross Profit Margin (Quarterly) | 14.73% |
| Profit Margin (Quarterly) | -1.52K% |
| Earnings Yield | -1.77K% |
| Normalized Earnings Yield | -1183.66 |